AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Chinese Migrant Population Health Cohort

Recruitingn/aAges 60 Years - 120 YearsAllJinwei Tian
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

The Chinese Migrant Population Health Cohort is a prospective, multi-center study jointly initiated by Professor Yong Ji, President of Harbin Medical University, and Academician Guoqiang Chen, President of Hainan Medical University, in collaboration with regional partners. It targets older adults (โ‰ฅ60 years) who engage in seasonal migration between cold (Heilongjiang) and tropical (Hainan) regions. The primary objective is to investigate cardiovascular and metabolic disease risks, underlying biological and environmental mechanisms, and effective preventive strategies in this unique population. Participants are recruited from both origin and destination sites and undergo standardized baseline assessments, including questionnaires, physical examinations, medical imaging, biospecimen collection (blood, stool, hair, nails), and environmental exposure monitoring. Longitudinal follow-up inclu

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: 1. Permanent residents of Harbin or Hainan who will continue to reside in Harbin or Hainan for the next 5 years. 2. Baseline age โ‰ฅ60 years, with basic communication and comprehension abilities. 3. No confirmed diagnosis of end-stage major organic diseases (e.g., advanced heart failure, advanced liver failure, advanced kidney failure, malignant tumors). 4. Able to perform activities of daily living independently and capable of completing questionnaires and physical examinations. 5. Willing to participate in the study, provide written informed consent, accept long-term follow-up, and provide biological specimens. Exclusion Criteria: 1. Occurrence of life-threatening acute events (e.g., myocardial infarction, acute heart failure, stroke) within the past 30 days. 2. Currently receiving chronic treatment with antiviral drugs (e.g., for HIV) or antipsychotic medications. 3. Presence of moderate to severe cognitive impairment preventing survey completion or follow-up cooperation. 4. Current acute infectious diseases such as influenza or fever. 5. Simultaneous participation in other interventional clinical studies. 6. Refusal to sign informed consent or unwillingness to provide biological specimens. 7. Any other condition deemed unsuitable for study participation by the investigators based on overall assessment.
๐Ÿ’Š

What it tests

  • No intervention
๐Ÿ“

Where

1 site
Harbin Medical University
Harbin, China
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy